NCT00752635View on ClinicalTrials.gov

Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

September 30, 2005

Conditions
Acne Vulgaris
Interventions
DRUG

Norgestimate-ethinyl estradiol; Cyproterone acetate-ethinyl estradiol

Sponsors
All Listed Sponsors
lead

Johnson & Johnson Taiwan Ltd

INDUSTRY